| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2001 | HEALTH RESEARCH, INC - ALBANY DIVISION | | | | | | | C06RR014537 | EXTRAMURAL RES FACILITIES CONSTR PROJ | 000 | 1 | NIH | 11/4/2018 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = -$53,982 ) |
| | 2016 | 2013 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R21ES021359 | Climate Change and Adverse Birth Outcomes | 001 | 2 | NIH | 12/29/2015 | -$53,982 |
|
| Issue Date FY: 2015 ( Subtotal = $0 ) |
| | 2015 | 2013 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R21ES021359 | Climate Change and Adverse Birth Outcomes | 000 | 2 | NIH | 4/2/2015 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = -$80,000 ) |
| | 2014 | 2013 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 005 | 9 | NIH | 9/18/2014 | $160,000 |
| | 2014 | 2013 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 004 | 9 | NIH | 9/17/2014 | -$160,000 |
| | 2014 | 2012 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 001 | 9 | NIH | 9/16/2014 | -$80,000 |
| | 2014 | 2012 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 000 | 9 | NIH | 6/12/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $517,618 ) |
| | 2013 | 2013 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 000 | 9 | NIH | 8/2/2013 | $371,520 |
| | 2013 | 2013 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R21ES021359 | Climate Change and Adverse Birth Outcomes | 001 | 2 | NIH | 6/25/2013 | $71,558 |
| | 2013 | 2013 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R21ES021359 | Climate Change and Adverse Birth Outcomes | 000 | 2 | NIH | 5/31/2013 | $74,540 |
|
| Issue Date FY: 2012 ( Subtotal = $867,054 ) |
| | 2012 | 2012 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 000 | 9 | NIH | 7/4/2012 | $321,548 |
| | 2012 | 2012 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 001 | 9 | NIH | 9/17/2012 | $370,171 |
| | 2012 | 2012 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 002 | 9 | NIH | 9/18/2012 | $0 |
| | 2012 | 2012 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R21ES021359 | Climate Change and Adverse Birth Outcomes | 000 | 1 | NIH | 5/25/2012 | $175,335 |
|
| Issue Date FY: 2011 ( Subtotal = $324,621 ) |
| | 2011 | 2011 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 000 | 8 | NIH | 7/26/2011 | $324,621 |
|
| Issue Date FY: 2010 ( Subtotal = $333,739 ) |
| | 2010 | 2010 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 000 | 7 | NIH | 6/29/2010 | $333,739 |
|
| Issue Date FY: 2009 ( Subtotal = $472,992 ) |
| | 2009 | 2009 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R25CA114101 | EPIDEMIOLOGIC AND BASIC SCIENCE IN CANCER PREVENTION | 002 | 4 | NIH | 9/29/2009 | $248,377 |
| | 2009 | 2009 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 004 | 6 | NIH | 9/11/2009 | $6,183 |
| | 2009 | 2009 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 003 | 6 | NIH | 8/12/2009 | $323,959 |
| | 2009 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01GM055440 | Time-resolved Cryo-EM of Short-lived States in Eukaryotic Translation | 000 | 11 | NIH | 11/25/2008 | $61,358 |
| | 2009 | 2007 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA106186 | QUANTITATIVE GENE EXPRESSION IN HUMAN LUNG EPITHELIUM | 000 | 5 | NIH | 4/13/2009 | $0 |
| | 2009 | 2007 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA106186 | QUANTITATIVE GENE EXPRESSION IN HUMAN LUNG EPITHELIUM | 001 | 5 | NIH | 5/26/2009 | -$166,885 |
| | 2009 | 2007 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 002 | 5 | NIH | 9/9/2009 | $0 |
| | 2009 | 2007 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 001 | 5 | NIH | 8/12/2009 | $0 |
| | 2009 | 2007 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA092596 | Human CYP2A and respiratory tract xenobiotic toxicity | 000 | 5 | NIH | 3/12/2009 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $4,944,349 ) |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01GM055440 | Time-resolved Cryo-EM of Short-lived States in Eukaryotic Translation | 000 | 11 | NIH | 3/21/2008 | $95,385 |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA130995 | Replication Licensing in Genome Stability, Cancer and Aging | 000 | 1 | NIH | 4/4/2008 | $359,974 |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | U3RHS007558 | Bioterrorism- Hospital Preparedness Program | 5 | 1 | ASPR | 11/20/2007 | $2,525,212 |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01AG023510 | STEM CELLS AND AGING | 000 | 4 | NIH | 5/27/2008 | $205,763 |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | F32GM077911 | THE ORIGIN AND ROLE OF KINETOCHORE FIBERS DURING MITOSIS | 000 | 3 | NIH | 5/27/2008 | $48,796 |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | D70MC06893 | STATE IMPLEMENTATION GRANTS FOR INTEGRATED COMMUNITY SYSTEMS FOR CSHCN | 0 | 3 | HRSA | 4/23/2008 | $295,500 |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | U62PS000271 | ENHANCED HIV/AIDS SUREILLANCE FOR PERINATAL PRVENTION | 000 | 3 | CDC | 12/20/2007 | $185,877 |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | U62PS224451 | PS04-155, MORBIDITY AND RISK BEHAVIOR SURVEILLANCE | 001 | 4 | CDC | 5/27/2008 | $260,627 |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R01CA133072 | EXPRESSION PROFILING OF RENAL CELL CARCINOMA UTILIZING TISSUE FROM CALGB 90206 | 000 | 1 | NIH | 7/4/2008 | $544,855 |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R21EB007782 | DEVELOPMENT OF HYBRID NEURAL PROSTHETIC DEVICES | 000 | 2 | NIH | 7/29/2008 | $197,275 |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R13CA095124 | LONG-TERM COMPLICATIONS OF CHILDREN/ADOLESCENTS & CANCER | 000 | 4 | NIH | 5/30/2008 | $15,618 |
| | 2008 | 2008 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | R21CA124116 | A study evaluating the effect of flaxseed on biomarkers of breast cancer risk | 000 | 1 | NIH | 3/13/2008 | $209,467 |
| | 2008 | 2007 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | U3REP070036 | HOSPITAL PREPAREDNESS PROGRAM | 6 | 1 | ASPR | 1/9/2008 | $14,561,258 |
| | 2008 | 2007 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | U3REP070036 | HOSPITAL PREPAREDNESS PROGRAM | 5 | 1 | ASPR | 11/26/2007 | -$14,561,258 |
| | 2008 | 2007 | HEALTH RESEARCH, INC - ALBANY DIVISION | 1 UNIVERSITY PLACE | RENSSELAER | NY | 12144 | RENSSELAER | USA | U3REP070036 | HOSPITAL PREPAREDNESS PROGRAM | 2 | 1 | ASPR | 10/18/2007 | $0 |
|
|
